Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors

被引:132
|
作者
Xu, KL
Ma, H
McCown, TJ
Verma, IM
Kafri, T
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[4] Salk Inst, Genet Lab, La Jolla, CA 92307 USA
关键词
lentiviral vectors; transduction; expression; neurons;
D O I
10.1006/mthe.2000.0238
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To facilitate the generation of SIN lentivirus vector-producer cell lines, we have developed a novel conditional SIN (cSIN) lentivirus vector, which retains its SIN properties in normal target cells yet can be produced at high titers from tetracycline-regulated packaging cell lines. The design of the cSIN vector is based on replacing the vector U3 transcription regulatory elements with the Tet-responsive element, which allows vector production exclusively in cells expressing the synthetic Tet-regulated transactivator (tTA). In contrast minimal vector production (similar to 200 IU/ml) is obtained in target cells that do not express the tTA, even in the presence of all HIV-1 proteins. Following transduction of the Tet-regulated SODk1 lentivirus vector-packaging cell line with the cSIN vector, high titers of cSIN recombinant vector (>10(6) IU/ml) could be generated, which efficiently transduced terminally differentiated neurons in normal rat brain.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [41] Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease
    Déglon, N
    Tseng, JL
    Bensadoun, JC
    Zurn, AD
    Arsenijevic, Y
    De Almeida, LP
    Zufferey, R
    Trono, D
    Aebischer, P
    HUMAN GENE THERAPY, 2000, 11 (01) : 179 - 190
  • [42] High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
    Moreau-Gaudry, F
    Xia, P
    Jiang, G
    Perelman, NP
    Bauer, G
    Ellis, J
    Surinya, KH
    Mavilio, F
    Shen, CK
    Malik, P
    BLOOD, 2001, 98 (09) : 2664 - 2672
  • [43] Upstream Polyadenylation Enhancers in the U3 Region of Self-Inactivating Retroviral and Lentiviral Vectors Improve Titer and Gene Expression, and Prevent Transcriptional Read-Through
    Schambach, Axel
    Galla, Melanie
    Christopher, Baum
    MOLECULAR THERAPY, 2006, 13 : S407 - S407
  • [44] Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
    Labenski, Verena
    Suerth, Julia D.
    Barczak, Elke
    Heckl, Dirk
    Levy, Camille
    Bernadin, Ornellie
    Charpentier, Emmanuelle
    Williams, David A.
    Fehse, Boris
    Verhoeyen, Els
    Schambach, Axel
    BIOMATERIALS, 2016, 97 : 97 - 109
  • [45] Jugular Vein Injection of High-Titer Lentiviral Vectors Does Not Transduce the Aorta-Brief Report
    Bi, Lianxiang
    Wacker, Bradley K.
    Stamatikos, Alexis
    Sethuraman, Meena
    Komandur, Kaushik
    Dichek, David A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (03) : 1149 - 1155
  • [46] Generation of novel self-inactivating retroviral vectors for gene therapy of Wiskott-Aldrich-Syndrome
    Diez, Avedillo, I
    Dewey, R. A.
    Schambach, A.
    Baum, C.
    Klein, C.
    KLINISCHE PADIATRIE, 2007, 219 (03): : 182 - 182
  • [47] Clonal Analysis Demonstrates Widespread Transcriptional Termination Read-through in Keratinocytes Transduced with Self-Inactivating Lentiviral Vectors
    Almarza, D.
    Larcher, F.
    Murillas, R.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1039 - 1040
  • [48] Transduction of Human CD34+ Repopulating Cells with a Self-Inactivating Lentiviral Vector for SCID-X1 Produced at Clinical Scale by a Stable Cell Line
    Greene, Michael R.
    Lockey, Timothy
    Mehta, Perdeep K.
    Kim, Yoon-Sang
    Eldridge, Paul W.
    Gray, John T.
    Sorrentino, Brian P.
    HUMAN GENE THERAPY METHODS, 2012, 23 (05) : 297 - 308
  • [49] Self-inactivating lentiviral vectors designed for liver gene transfer do not display detectable genotoxicity in sensitive in vivo assays
    Ranzani, M.
    Cantore, A.
    Volpin, M.
    Sanvito, F.
    Gallina, P.
    Bartholomae, C.
    Benedicenti, F.
    Sergi, L.
    Cesana, D.
    Doglioni, C.
    von Kalle, C.
    Schmidt, M.
    Naldini, I.
    Montini, E.
    HUMAN GENE THERAPY, 2011, 22 (10) : A60 - A60
  • [50] A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration
    R Loew
    Y Meyer
    K Kuehlcke
    L Gama-Norton
    D Wirth
    H Hauser
    S Stein
    M Grez
    S Thornhill
    A Thrasher
    C Baum
    A Schambach
    Gene Therapy, 2010, 17 : 272 - 280